Lite Strategy, Inc. (LITS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lite Strategy, Inc. (LITS) has a cash flow conversion efficiency ratio of -0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.51 Million) by net assets ($112.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LITS company net worth for the company's overall valuation and market capitalisation.
Lite Strategy, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Lite Strategy, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lite Strategy, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lite Strategy, Inc. ranked by their cash flow conversion efficiency. Explore LITS cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mirae Asset Global REIT Co. Ltd.
KO:396690
|
-0.005x |
|
Kishin Corporation
KO:092440
|
0.004x |
|
Stablecoin Development Corporation
NYSE MKT:SDEV
|
0.100x |
|
KCI Limited
KQ:036670
|
0.005x |
|
Perdana Bangun Pusaka Tbk PT
JK:KONI
|
0.056x |
|
EYG Gayrimenkul Yatirim Ortakligi A.S.
IS:EYGYO
|
0.020x |
|
Delticom AG
F:DEX
|
-0.008x |
|
Enogia SAS
PA:ALENO
|
-0.053x |
Annual Cash Flow Conversion Efficiency for Lite Strategy, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Lite Strategy, Inc. from 2021 to 2025. View LITS share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $16.93 Million | $-20.84 Million | -1.231x | +19.46% |
| 2024-06-30 | $33.02 Million | $-50.47 Million | -1.529x | +28.28% |
| 2023-06-30 | $24.62 Million | $-52.48 Million | -2.131x | -129.18% |
| 2022-06-30 | $52.41 Million | $-48.75 Million | -0.930x | -43.93% |
| 2021-06-30 | $49.47 Million | $-31.96 Million | -0.646x | -- |
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.